
The stitches come out, the wound has closed, and the advice that follows is almost always the same: leave it alone for a year and see how it settles. That guidance is not baseless, since scars do remodel and soften on their own over many months. It has also been overtaken by a body of evidence suggesting that the early weeks are an opportunity rather than a waiting period.
The question of when to intervene turns out to be as consequential as which device is used. Understanding laser treatment for surgical scars means understanding the window in which the scar is still actively remodelling, and what can reasonably be expected once it has closed.
Why early intervention has a rationale
A healing wound passes through inflammation, proliferation and then a prolonged remodelling phase in which collagen is laid down, reorganised and gradually matured. Intervening while that remodelling is still under way means influencing a process that is already in motion, instead of attempting to undo a settled result.
An expert panel of dermatologists and plastic surgeons concluded that ablative fractional photothermolysis represents a significant advance in restoring both function and cosmetic appearance in in restoring both function and cosmetic appearance in scars, and recommended a prominent role for laser treatment in scar management, explicitly including early intervention for contracture avoidance and assistance with wound healing1. That panel was considering traumatic scars, so the conclusions transfer to elective surgical scars with some caution.
What the evidence shows
A systematic review and meta-analysis screened 4,397 abstracts, included eight studies and pooled four, finding that laser intervention was favoured with a standardised mean difference of 0.39 and a 95 per cent confidence interval of 0.05 to 0.742. The authors concluded that the evidence supports laser treatment of primarily closed surgical scars applied within one month after surgery2. The lower bound of that interval sits close to null, so the honest reading is a small to moderate benefit, not a transformation.
Timing itself has been examined directly in Asian patients. A retrospective cohort of 52 patients treated with pulsed dye laser for post-traumatic and surgical scars found that 82.7 per cent responded favourably, and that treatment timing correlated with improvement on both the Manchester and Vancouver scar scales3. Patients treated within ten weeks of injury scored significantly better than those treated later, with Manchester scores of 7.5 against 9.3 and Vancouver scores of 2.8 against 4.53.
A split-scar study offers a sense of what a course looks like in practice. Eighteen women, mean age 51.3 years, received three sessions of pulsed dye laser combined with fractional ablative carbon dioxide laser at monthly intervals, beginning within six weeks of suture removal, with one half of each scar treated and the other half left as a comparison4. At six months after the final session, blinded physician evaluators and the patients themselves rated the treated halves as significantly improved across all assessed parameters, with no remarkable adverse events4.
Balance requires noting the counterexample. A randomised controlled trial applying a single pulsed dye laser treatment at suture removal found no significant difference between treated and untreated scars at six weeks, with both improving over time5. Read together with the positive studies, which all used a course of treatments, the reasonable conclusion is that early and repeated intervention carries evidence behind it while a single early pass does not.
Medical reasons, cosmetic reasons
Scars are not solely an appearance concern. A scar crossing a joint or a flexural crease can restrict movement, and contracture, tethering, persistent itch and pain are functional problems with functional reasons to treat them. The consensus panel framed laser scar work in exactly those terms, as restoration of function alongside appearance1.
Where treatment is undertaken for appearance alone, it sits in a different category, and the trade-offs of cost, downtime and the possibility of an unsatisfactory result deserve to be weighed openly. Both indications are legitimate. Conflating them is what leads to unrealistic expectations.
Skin type changes the risk calculation
Post-inflammatory hyperpigmentation is the complication of greatest concern for Fitzpatrick skin types III to VI, which covers a large share of the Singapore population. A study of 37 Chinese patients across 119 fractional resurfacing sessions recorded generalised hyperpigmentation in 7.1 per cent of high-energy, low-density sessions and 12.4 per cent of low-energy, high-density sessions6.
The pattern in that data is instructive: treatment density appeared to influence risk more than energy did, and localised pigmentation clustered in areas that lacked air cooling6. Post-inflammatory hyperpigmentation is therefore substantially a question of parameter selection and operator judgement, not an unavoidable consequence of having darker skin. Those figures come from early fractional devices, and contemporary practice has moved on with better therapeutic outcomes, but the principle holds.
When laser is not the first move
Patients prone to keloid or hypertrophic scarring need a different plan, since energy delivered into a scar that is already overproducing collagen can aggravate it. International scar management recommendations advise that a combination approach using multiple modalities offers the strongest prospect for hypertrophic scars and keloids7. Anyone who has already formed a thickened scar should read about managing hypertrophic and keloid scars before assuming laser alone is the answer.
Active infection, unhealed wounds, and certain photosensitising medicines are all reasons to delay. Assessment before treatment exists to catch these.
Conclusion
Waiting a full year before doing anything is no longer the only defensible approach, though the alternative is a considered course of treatment started at the right point and matched to your skin, not a single session booked in haste. At Angeline Yong Dermatology, Dr Angeline Yong assesses the scar, the site, your skin type and your healing history before advising on the right treatment options and when would be the best time to start treatment. Book a consultation to discuss where your scar sits on that timeline.
References
Anderson, R. R., Donelan, M. B., Hivnor, C., Greeson, E., Ross, E. V., Shumaker, P. R., Uebelhoer, N. S., & Waibel, J. S. (2014). Laser treatment of traumatic scars with an emphasis on ablative fractional laser resurfacing: Consensus report. JAMA Dermatology, 150(2), 187-193. https://doi.org/10.1001/jamadermatol.2013.7761
Kent, R. A., Shupp, J., Fernandez, S., Prindeze, N., & DeKlotz, C. M. C. (2020). Effectiveness of early laser treatment in surgical scar minimization: A systematic review and meta-analysis. Dermatologic Surgery, 46(3), 402-410. https://doi.org/10.1097/DSS.0000000000001887
Chang, H. Y., Wu, B. Q., Chang, C. C., Chen, Y. T., & Wang, Y. J. (2025). Defining the treatment window: Early versus late pulsed dye laser therapy for posttraumatic and surgical scars in Asian patients. Lasers in Surgery and Medicine, 57(1), 71-79. https://doi.org/10.1002/lsm.23844
Safra, T., Shehadeh, W., Koren, A., Salameh, F., Friedman, O., Sprecher, E., & Artzi, O. (2019). Early intervention with pulse dye and CO2 ablative fractional lasers to improve cutaneous scarring post-lumpectomy: A randomized controlled trial on the impact of intervention on final cosmesis. Lasers in Medical Science, 34(9), 1881-1887. https://doi.org/10.1007/s10103-019-02788-3
Alam, M., Pon, K., Van Laborde, S., Kaminer, M. S., Arndt, K. A., & Dover, J. S. (2006). Clinical effect of a single pulsed dye laser treatment of fresh surgical scars: Randomized controlled trial. Dermatologic Surgery, 32(1), 21-25. https://doi.org/10.1111/1524-4725.2006.32029
Chan, H. H., Manstein, D., Yu, C. S., Shek, S., Kono, T., & Wei, W. I. (2007). The prevalence and risk factors of post-inflammatory hyperpigmentation after fractional resurfacing in Asians. Lasers in Surgery and Medicine, 39(5), 381-385. https://doi.org/10.1002/lsm.20512
Gold, M. H., McGuire, M., Mustoe, T. A., Pusic, A., Sachdev, M., Waibel, J., & Murcia, C. (2014). Updated international clinical recommendations on scar management: Part 2. Algorithms for scar prevention and treatment. Dermatologic Surgery, 40(8), 825-831. https://laserplast.org/wp-content/uploads/Updated_International_Clinical_Recommendations_on.1.pdf


